Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
02.01.24
/
50%
€28.47
Target price
02.01.25
€33.76
Performance (%)
-40.04%
Price
03.10.24
€17.07
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc. is performing very badly with a performance of -40.04%. This prediction currently runs until 02.01.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -2.735% | -2.735% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Bank of America Co. from $29.00 to $37.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.76
04.12.23
04.12.23
€26.71
04.12.24
04.12.24
-21.55%
03.10.24
03.10.24